Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use

Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older

Related Keywords

United States , South Africa , Canada , United Kingdom , Brazil , Americans , Albert Bourla , Ugur Sahin , Linkedin , Twitter , Drug Administration , Pfizer , Youtube , European Union , Facebook , Ipfizer Inc , Use Authorization , Include Individuals , Germanyi November , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Prescribing Information , Breakthroughs That Change Patient , Pfizer News , Vaccine , Immunotherapy , Immune Therapy , Desensitization , Personalized Immunotherapy , Ntigen , Ellular , Recombinant , Protein , Peptide , Subunit , Multivalent , Cancer Vaccine ,